The University of Chicago Header Logo

Connection

Olwen Hahn to Neovascularization, Pathologic

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Neovascularization, Pathologic.
Olwen Hahn
Connection Strength
0.040
Neovascularization, Pathologic
  1. Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance). J Clin Oncol. 2021 08 01; 39(22):2486-2496.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.